Ad5: Phase II data

Top-line combined data from the 2 highest dose groups of RT-100 in a double-blind, U.S. Phase II trial in 56 symptomatic heart failure patients with

Read the full 257 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE